{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T03:26:35Z","timestamp":1780457195322,"version":"3.54.1"},"reference-count":155,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1053\/j.semdp.2020.11.002","type":"journal-article","created":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T11:15:24Z","timestamp":1606475724000},"page":"137-151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Undifferentiated and dedifferentiated neoplasms of the female genital tract"],"prefix":"10.1053","volume":"38","author":[{"given":"Jennifer A.","family":"Bennett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semdp.2020.11.002_bib0001","author":"Tavassoli","year":"2003","journal-title":"Tumors of the breast and female genital organs: World Health Organization classification of tumors"},{"key":"10.1053\/j.semdp.2020.11.002_bib0002","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1097\/01.pas.0000171003.72352.9a","article-title":"Undifferentiated carcinoma of the endometrium","volume":"29","author":"Altrabulsi","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0003","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/01.pgp.0000183048.22588.18","article-title":"Association of low-grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma: a new type of dedifferentiated carcinoma?","volume":"25","author":"Silva","year":"2006","journal-title":"Int J Gynecol Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0004","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/00313020601159494","article-title":"Undifferentiated carcinoma of the endometrium: a review","volume":"39","author":"Silva","year":"2007","journal-title":"Pathology"},{"key":"10.1053\/j.semdp.2020.11.002_bib0005","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/PGP.0b013e3181895539","article-title":"The significance of neuroendocrine expression in undifferentiated carcinoma of the endometrium","volume":"28","author":"Taraif","year":"2009","journal-title":"Int J Gynecol Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0006","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/modpathol.2010.41","article-title":"Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms","volume":"23","author":"Tafe","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0007","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/PAS.0000000000000941","article-title":"Undifferentiated endometrial carcinomas show frequent loss of core switch\/sucrose nonfermentable complex proteins","volume":"42","author":"Kobel","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0008","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.ygyno.2006.05.039","article-title":"Radiation-associated endometrial cancers are prognostically unfavorable tumors: a clinicopathologic comparison with 527 sporadic endometrial cancers","volume":"103","author":"Pothuri","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0009","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/PAS.0b013e318197a046","article-title":"Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities","volume":"33","author":"Garg","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0010","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1136\/jcp.2009.064949","article-title":"Lynch syndrome (hereditary non-polyposis colorectal cancer) and endometrial carcinoma","volume":"62","author":"Garg","year":"2009","journal-title":"J Clin Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0011","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/modpathol.2016.156","article-title":"Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas","volume":"29","author":"Coatham","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0012","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1264565","article-title":"Immunological profiling of molecularly classified high-risk endometrial cancers identifies POLE-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition","volume":"6","author":"Eggink","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1053\/j.semdp.2020.11.002_bib0013","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/annonc\/mdw552","article-title":"Targeting chromatin defects in selected solid tumors based on oncogene addiction, synthetic lethality and epigenetic antagonism","volume":"28","author":"Morel","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0014","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/PGP.0000000000000248","article-title":"Undifferentiated carcinoma of the endometrium: an expanded immunohistochemical analysis including PAX-8 and basal-like carcinoma surrogate markers","volume":"35","author":"Ramalingam","year":"2016","journal-title":"Int J Gynecol Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0015","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/pin.12557","article-title":"Dedifferentiated carcinoma with clear cell carcinoma of the endometrium: a case report","volume":"67","author":"Lee","year":"2017","journal-title":"Pathol Int"},{"key":"10.1053\/j.semdp.2020.11.002_bib0016","doi-asserted-by":"crossref","DOI":"10.1111\/his.14186","article-title":"Undifferentiated endometrial carcinoma arising in the background of high-grade endometrial carcinoma - expanding the definition of dedifferentiated endometrial carcinoma","author":"Busca","year":"2020","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2020.11.002_bib0017","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/modpathol.2015.155","article-title":"Loss of switch\/sucrose non-fermenting complex protein expression is associated with dedifferentiation in endometrial carcinomas","volume":"29","author":"Karnezis","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0018","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.anndiagpath.2019.01.001","article-title":"Undifferentiated endometrial carcinoma: a selected immunohistochemical panel including PAX-8 and E-cadherin for aiding distinction from other endometrial carcinomas","volume":"39","author":"Zhang","year":"2019","journal-title":"Ann Diagn Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0019","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00428-019-02532-w","article-title":"Role of epithelial-mesenchymal transition factors in the histogenesis of uterine carcinomas","volume":"475","author":"Franceschi","year":"2019","journal-title":"Virchows Arch"},{"key":"10.1053\/j.semdp.2020.11.002_bib0020","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/his.12989","article-title":"Immunophenotypic features of dedifferentiated endometrial carcinoma - insights from BRG1\/INI1-deficient tumours","volume":"69","author":"Hoang","year":"2016","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2020.11.002_bib0021","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/PAI.0000000000000232","article-title":"Clinicopathologic and immunohistochemical characterization of dedifferentiated endometrioid adenocarcinoma","volume":"24","author":"Li","year":"2016","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0022","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.humpath.2017.11.006","article-title":"Dedifferentiated endometrial carcinomas with neuroendocrine features: a clinicopathologic, immunohistochemical, and molecular genetic study","volume":"72","author":"Espinosa","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0023","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1038\/modpathol.2013.93","article-title":"ZEB1 overexpression associated with E-cadherin and microRNA-200 downregulation is characteristic of undifferentiated endometrial carcinoma","volume":"26","author":"Romero-Perez","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0024","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/PAT.0000000000000270","article-title":"SWI\/SNF complex deficiency and mismatch repair protein expression in undifferentiated and dedifferentiated endometrial carcinoma","volume":"47","author":"Stewart","year":"2015","journal-title":"Pathology"},{"key":"10.1053\/j.semdp.2020.11.002_bib0025","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/modpathol.2016.132","article-title":"Molecular genetic heterogeneity in undifferentiated endometrial carcinomas","volume":"29","author":"Rosa-Rosa","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0026","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/his.13091","article-title":"Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology","volume":"70","author":"Ramalingam","year":"2017","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2020.11.002_bib0027","first-page":"20","article-title":"Dedifferentiated endometrial carcinoma could be A target for immune checkpoint inhibitors (Anti PD-1\/PD-L1 antibodies)","author":"Ono","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1053\/j.semdp.2020.11.002_bib0028","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/cncr.21560","article-title":"Pathologic features of endometrial carcinoma associated with HNPCC: a comparison with sporadic endometrial carcinoma","volume":"106","author":"Broaddus","year":"2006","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2020.11.002_bib0029","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.anndiagpath.2015.04.001","article-title":"Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant","volume":"19","author":"Strehl","year":"2015","journal-title":"Ann Diagn Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0030","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/PAI.0000000000000374","article-title":"A selected immunohistochemical panel aids in differential diagnosis and prognostic stratification of subtypes of high-grade endometrial carcinoma: a clinicopathologic and immunohistochemical study at a single institution","volume":"25","author":"Taskin","year":"2017","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0031","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1097\/PAS.0000000000000873","article-title":"Undifferentiated and dedifferentiated endometrial carcinomas with POLE exonuclease domain mutations have a favorable prognosis","volume":"41","author":"Espinosa","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0032","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/his.13525","article-title":"Frequent loss of claudin-4 expression in dedifferentiated and undifferentiated endometrial carcinomas","volume":"73","author":"Tessier-Cloutier","year":"2018","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2020.11.002_bib0033","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/PAS.0000000000001375","article-title":"SMARCA4-deficient uterine sarcoma and undifferentiated endometrial carcinoma are distinct clinicopathologic entities","volume":"44","author":"Kolin","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0034","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/modpathol.2016.230","article-title":"Claudin-4 expression distinguishes SWI\/SNF complex-deficient undifferentiated carcinomas from sarcomas","volume":"30","author":"Schaefer","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0035","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.humpath.2015.06.011","article-title":"Fascin expression in undifferentiated and dedifferentiated endometrial carcinoma","volume":"46","author":"Stewart","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0036","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1038\/modpathol.2015.102","article-title":"A role for the transducer of the Hippo pathway, TAZ, in the development of aggressive types of endometrial cancer","volume":"28","author":"Romero-Perez","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0037","doi-asserted-by":"crossref","first-page":"e6248","DOI":"10.1097\/MD.0000000000006248","article-title":"High expression of SALL4 and fascin, and loss of E-cadherin expression in undifferentiated\/dedifferentiated carcinomas of the endometrium: an immunohistochemical and clinicopathologic study","volume":"96","author":"Onder","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1053\/j.semdp.2020.11.002_bib0038","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/PGP.0000000000000449","article-title":"Undifferentiated endometrial carcinoma, an immunohistochemical study including PD-L1 testing of a series of cases from a single cancer center","volume":"37","author":"Al-Hussaini","year":"2018","journal-title":"Int J Gynecol Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0039","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/PAS.0000000000000427","article-title":"Cyclin D1 does not distinguish YWHAE-NUTM2 high-grade endometrial stromal sarcoma from undifferentiated endometrial carcinoma","volume":"39","author":"Shah","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0040","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/his.13019","article-title":"CD34 expression in undifferentiated endometrial carcinoma","volume":"69","author":"Shah","year":"2016","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2020.11.002_bib0041","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/PGP.0b013e318223118a","article-title":"P16INK4a expression in undifferentiated carcinoma of the uterus does not exclude its endometrial origin","volume":"31","author":"Saad","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0042","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/PAS.0000000000000166","article-title":"Molecular characterization of undifferentiated carcinoma associated with endometrioid carcinoma","volume":"38","author":"Kuhn","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0043","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/modpathol.2011.208","article-title":"Clinical assessment of PTEN loss in endometrial carcinoma: immunohistochemistry outperforms gene sequencing","volume":"25","author":"Djordjevic","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0044","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/ng.2928","article-title":"Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4","volume":"46","author":"Ramos","year":"2014","journal-title":"Nat Genet"},{"key":"10.1053\/j.semdp.2020.11.002_bib0045","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/ng.2931","article-title":"Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type","volume":"46","author":"Witkowski","year":"2014","journal-title":"Nat Genet"},{"key":"10.1053\/j.semdp.2020.11.002_bib0046","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/path.4056","article-title":"Use of mutation profiles to refine the classification of endometrial carcinomas","volume":"228","author":"McConechy","year":"2012","journal-title":"J Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0047","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1097\/PAS.0000000000000640","article-title":"Mixed and ambiguous endometrial carcinomas: a heterogenous group of tumors with different clinicopathologic and molecular genetic features","volume":"40","author":"Espinosa","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0048","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Cancer Genome Atlas Research","year":"2013","journal-title":"Nature"},{"key":"10.1053\/j.semdp.2020.11.002_bib0049","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/PGP.0b013e3182a54afa","article-title":"PAX8 expression in uterine adenocarcinomas and mesonephric proliferations","volume":"33","author":"Yemelyanova","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0050","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/PGP.0b013e3181cd6552","article-title":"High-grade endometrial carcinoma: serous and grade 3 endometrioid carcinomas have different immunophenotypes and outcomes","volume":"29","author":"Alkushi","year":"2010","journal-title":"Int J Gynecol Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0051","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00428-018-02516-2","article-title":"Targeted sequencing with a customized panel to assess histological typing in endometrial carcinoma","volume":"474","author":"Cuevas","year":"2019","journal-title":"Virchows Arch"},{"key":"10.1053\/j.semdp.2020.11.002_bib0052","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1097\/PAS.0000000000001434","article-title":"Mismatch repair deficiency in uterine carcinosarcoma: a multi-institution retrospective review","volume":"44","author":"Jenkins","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0053","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/PAS.0000000000000633","article-title":"Neuroendocrine carcinoma of the endometrium: a clinicopathologic study of 25 cases","volume":"40","author":"Pocrnich","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"Suppl 1","key":"10.1053\/j.semdp.2020.11.002_bib0054","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1097\/PGP.0000000000000491","article-title":"High-grade endometrial carcinomas: morphologic and immunohistochemical features, diagnostic challenges and recommendations","volume":"38","author":"Murali","year":"2019","journal-title":"Int J Gynecol Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0055","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ygyno.2016.11.020","article-title":"A new marker, insulinoma-associated protein 1 (INSM1), for high-grade neuroendocrine carcinoma of the uterine cervix: analysis of 37 cases","volume":"144","author":"Kuji","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0056","doi-asserted-by":"crossref","DOI":"10.1097\/PAS.0000000000001560","article-title":"Molecular characterization of neuroendocrine carcinomas of the endometrium: representation in all 4 TCGA groups","author":"Howitt","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0057","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/PAS.0b013e31824a7b1a","article-title":"The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor","volume":"36","author":"Lee","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0058","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1097\/PAS.0b013e31825fa931","article-title":"Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangement","volume":"36","author":"Lee","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0059","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/modpathol.2013.199","article-title":"Frequent expression of KIT in endometrial stromal sarcoma with YWHAE genetic rearrangement","volume":"27","author":"Lee","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0060","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1038\/s41379-018-0049-z","article-title":"SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma","volume":"31","author":"Kolin","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0061","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1038\/s41379-019-0303-z","article-title":"SMARCA4 inactivation defines a subset of undifferentiated uterine sarcomas with rhabdoid and small cell features and germline mutation association","volume":"32","author":"Lin","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0062","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/00000478-199411000-00004","article-title":"Small cell carcinoma of the ovary, hypercalcemic type. A clinicopathological analysis of 150 cases","volume":"18","author":"Young","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0063","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/ng.2922","article-title":"Recurrent SMARCA4 mutations in small cell carcinoma of the ovary","volume":"46","author":"Jelinic","year":"2014","journal-title":"Nat Genet"},{"key":"10.1053\/j.semdp.2020.11.002_bib0064","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/1097-0142(19820101)49:1<188::AID-CNCR2820490137>3.0.CO;2-D","article-title":"Small cell carcinoma of the ovary with hypercalcemia: a report of eleven cases","volume":"49","author":"Dickersin","year":"1982","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2020.11.002_bib0065","first-page":"9","article-title":"Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) beyond SMARCA4 mutations: a comprehensive genomic analysis","author":"Auguste","year":"2020","journal-title":"Cells"},{"key":"10.1053\/j.semdp.2020.11.002_bib0066","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/PAS.0b013e31820a406c","article-title":"FOXL2 is a sensitive and specific marker for sex cord-stromal tumors of the ovary","volume":"35","author":"Al-Agha","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0067","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1097\/PAS.0000000000001296","article-title":"Adult granulosa cell tumor with high-grade transformation: report of a series with FOXL2 mutation analysis","volume":"43","author":"Fashedemi","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0068","article-title":"WHO classification of tumours of female reproductive organs","author":"Kurman","year":"2014","journal-title":"Lyon: World Health Organization"},{"key":"10.1053\/j.semdp.2020.11.002_bib0069","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/PAS.0b013e31816a3b42","article-title":"Endometrial stromal sarcomas and related high-grade sarcomas: immunohistochemical and molecular genetic study of 31 cases","volume":"32","author":"Kurihara","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0070","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/PAS.0000000000001215","article-title":"Undifferentiated uterine sarcomas represent under-recognized high-grade endometrial stromal sarcomas","volume":"43","author":"Cotzia","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0071","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/ijc.29141","article-title":"A prognosis based classification of undifferentiated uterine sarcomas: identification of mitotic index, hormone receptors and YWHAE-FAM22 translocation status as predictors of survival","volume":"136","author":"Gremel","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1053\/j.semdp.2020.11.002_bib0072","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1097\/PAS.0000000000000894","article-title":"Validation of a mitotic index cutoff as a prognostic marker in undifferentiated uterine sarcomas","volume":"41","author":"Hardell","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0073","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1158\/1078-0432.CCR-18-2792","article-title":"Integrated molecular analysis of undifferentiated uterine sarcomas reveals clinically relevant molecular subtypes","volume":"25","author":"Binzer-Panchal","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"Suppl 1","key":"10.1053\/j.semdp.2020.11.002_bib0074","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1038\/modpathol.2015.139","article-title":"Practical issues in uterine pathology from banal to bewildering: the remarkable spectrum of smooth muscle neoplasia","volume":"29","author":"Oliva","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0075","first-page":"466","article-title":"Histological and immunohistochemical observations of dedifferentiated leiomyosarcoma of the uterus","volume":"41","author":"Fukuda","year":"1991","journal-title":"Acta Pathol Jpn"},{"key":"10.1053\/j.semdp.2020.11.002_bib0076","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1365-2559.2011.04070.x","article-title":"Dedifferentiated leiomyosarcoma: clinicopathological analysis of 18 cases","volume":"59","author":"Chen","year":"2011","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2020.11.002_bib0077","article-title":"Dedifferentiated leiomyosarcoma of the uterus with heterologous elements: a potential diagnostic pitfall","volume":"2012","author":"Rawish","year":"2012","journal-title":"Case Rep Obstet Gynecol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0078","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/PGP.0b013e31815ea7f5","article-title":"Immunohistochemical analysis of p16, p53, and Ki-67 expression in uterine smooth muscle tumors","volume":"27","author":"Chen","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0079","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/modpathol.2017.185","article-title":"Genome profiling is an efficient tool to avoid the STUMP classification of uterine smooth muscle lesions: a comprehensive array-genomic hybridization analysis of 77 tumors","volume":"31","author":"Croce","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005850","article-title":"Exome sequencing of uterine leiomyosarcomas identifies frequent mutations in TP53, ATRX, and MED12","volume":"12","author":"Makinen","year":"2016","journal-title":"PLoS Genet"},{"key":"10.1053\/j.semdp.2020.11.002_bib0081","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/01913129709021311","article-title":"The many faces of smooth muscle neoplasms in a gynecological sampling: an ultrastructural study","volume":"21","author":"Dickersin","year":"1997","journal-title":"Ultrastruct Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0082","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/PAP.0000000000000164","article-title":"Myxoid mesenchymal tumors of the uterus: an update on classification, definitions, and differential diagnosis","volume":"24","author":"Busca","year":"2017","journal-title":"Adv Anat Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0083","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/j.1365-2559.2011.04053.x","article-title":"Myxoid leiomyosarcoma of the uterus","volume":"59","author":"Burch","year":"2011","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2020.11.002_bib0084","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/PAS.0000000000000593","article-title":"Myxoid leiomyosarcoma of the uterus: a clinicopathologic analysis of 30 cases and review of the literature with reappraisal of its distinction from other uterine myxoid mesenchymal neoplasms","volume":"40","author":"Parra-Herran","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0085","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.humpath.2016.09.014","article-title":"Myxoid leiomyosarcoma of the uterus: a clinicopathological and immunohistochemical study of 10 cases","volume":"59","author":"Lu","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0086","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/PAS.0000000000001196","article-title":"Novel PLAG1 gene rearrangement distinguishes a subset of uterine myxoid leiomyosarcoma from other uterine myxoid mesenchymal tumors","volume":"43","author":"Arias-Stella","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0087","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/s41379-019-0299-4","article-title":"Myxoid smooth muscle neoplasia of the uterus: comprehensive analysis by next-generation sequencing and nucleic acid hybridization","volume":"32","author":"Yoon","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0088","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/his.13176","article-title":"Abnormal p53 and p16 staining patterns distinguish uterine leiomyosarcoma from inflammatory myofibroblastic tumour","volume":"70","author":"Schaefer","year":"2017","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2020.11.002_bib0089","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/PAS.0000000000000721","article-title":"Novel High-grade endometrial stromal sarcoma: a morphologic mimicker of myxoid leiomyosarcoma","volume":"41","author":"Hoang","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0090","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/modpathol.2017.162","article-title":"ZC3H7B-BCOR high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entity","volume":"31","author":"Lewis","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0091","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/modpathol.2017.42","article-title":"BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology","volume":"30","author":"Chiang","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0092","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ygyno.2020.02.024","article-title":"Genomic profiling of BCOR-rearranged uterine sarcomas reveals novel gene fusion partners, frequent CDK4 amplification and CDKN2A loss","volume":"157","author":"Lin","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0093","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/cjp2.165","article-title":"Endometrial stromal sarcomas with BCOR-rearrangement harbor MDM2 amplifications","volume":"6","author":"Kommoss","year":"2020","journal-title":"J Pathol Clin Res"},{"key":"10.1053\/j.semdp.2020.11.002_bib0094","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1126\/science.1092472","article-title":"In vivo activation of the p53 pathway by small-molecule antagonists of MDM2","volume":"303","author":"Vassilev","year":"2004","journal-title":"Science"},{"key":"10.1053\/j.semdp.2020.11.002_bib0095","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/PAS.0000000000001055","article-title":"NTRK fusions define a novel uterine sarcoma subtype with features of fibrosarcoma","volume":"42","author":"Chiang","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0096","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/s41379-018-0184-6","article-title":"Uterine and vaginal sarcomas resembling fibrosarcoma: a clinicopathological and molecular analysis of 13 cases showing common NTRK-rearrangements and the description of a COL1A1-PDGFB fusion novel to uterine neoplasms","volume":"32","author":"Croce","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0097","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/his.14069","article-title":"NTRK fusion cervical sarcoma: a report of three cases, emphasising morphological and immunohistochemical distinction from other uterine sarcomas, including adenosarcoma","volume":"77","author":"Rabban","year":"2020","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2020.11.002_bib0098","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/PAS.0b013e318208f72e","article-title":"Endocervical fibroblastic malignant peripheral nerve sheath tumor (neurofibrosarcoma): report of a novel entity possibly related to endocervical CD34 fibrocytes","volume":"35","author":"Mills","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0099","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41571-018-0113-0","article-title":"NTRK fusion-positive cancers and TRK inhibitor therapy","volume":"15","author":"Cocco","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0100","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1158\/1078-0432.CCR-15-1243","article-title":"Efficacy and biological activity of imatinib in metastatic Dermatofibrosarcoma Protuberans (DFSP)","volume":"22","author":"Stacchiotti","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semdp.2020.11.002_bib0101","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1097\/01.pas.0000172189.02424.91","article-title":"Inflammatory myofibroblastic tumor of the uterus: a clinicopathologic study of 6 cases emphasizing distinction from aggressive mesenchymal tumors","volume":"29","author":"Rabban","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0102","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/PAS.0000000000000330","article-title":"Inflammatory myofibroblastic tumor of the uterus: clinical and pathologic review of 10 cases including a subset with aggressive clinical course","volume":"39","author":"Parra-Herran","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0103","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/modpathol.2017.69","article-title":"Inflammatory myofibroblastic tumor of the uterus: a clinicopathological, immunohistochemical, and molecular analysis of 13 cases highlighting their broad morphologic spectrum","volume":"30","author":"Bennett","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0104","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/PAS.0000000000001525","article-title":"Inflammatory myofibroblastic tumor of the uterus: an immunohistochemical study of 23 cases","volume":"44","author":"Bennett","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0105","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/PAS.0000000000000801","article-title":"Uterine inflammatory myofibroblastic tumors frequently harbor ALK fusions with IGFBP5 and THBS1","volume":"41","author":"Haimes","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0106","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1097\/PAS.0000000000001481","article-title":"Pregnancy-associated inflammatory myofibroblastic tumors of the uterus are clinically distinct and highly enriched for TIMP3-ALK and THBS1-ALK fusions","volume":"44","author":"Devereaux","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0107","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1177\/0300060518780873","article-title":"Anaplastic lymphoma kinase-negative uterine inflammatory myofibroblastic tumor containing the ETV6-NTRK3 fusion gene: a case report","volume":"46","author":"Takahashi","year":"2018","journal-title":"J Int Med Res"},{"key":"10.1053\/j.semdp.2020.11.002_bib0108","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.humpath.2019.12.006","article-title":"Uterine inflammatory myofibroblastic tumors in pregnant women with and without involvement of the placenta: a study of 6 cases with identification of a novel TIMP3-RET fusion","volume":"97","author":"Cheek","year":"2020","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0109","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.humpath.2020.03.014","article-title":"Uterine inflammatory myofibroblastic tumor involving the decidua of the extraplacental membranes: report of a case with a TIMP3-ROS1 gene fusion","volume":"100","author":"Schoolmeester","year":"2020","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0110","first-page":"65","article-title":"Crizotinib in ALK(+) inflammatory myofibroblastic tumors-Current experience and future perspectives","author":"Theilen","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1053\/j.semdp.2020.11.002_bib0111","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/PAS.0000000000000993","article-title":"BCOR internal tandem duplication in high-grade uterine sarcomas","volume":"42","author":"Marino-Enriquez","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0112","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000493322","article-title":"A pan-cancer landscape analysis reveals a subset of endometrial stromal and pediatric tumors defined by internal tandem duplications of BCOR","volume":"96","author":"Juckett","year":"2019","journal-title":"Oncology"},{"key":"10.1053\/j.semdp.2020.11.002_bib0113","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/PAS.0000000000000133","article-title":"Perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract: clinicopathologic and immunohistochemical characterization of 16 cases","volume":"38","author":"Schoolmeester","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0114","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1097\/PAS.0000000000001119","article-title":"Uterine PEComas: a morphologic, immunohistochemical, and molecular analysis of 32 tumors","volume":"42","author":"Bennett","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0115","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/path.2289","article-title":"Constant allelic alteration on chromosome 16p (TSC2 gene) in perivascular epithelioid cell tumour (PEComa): genetic evidence for the relationship of PEComa with angiomyolipoma","volume":"214","author":"Pan","year":"2008","journal-title":"J Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0116","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/PAS.0000000000000389","article-title":"Dichotomy of genetic abnormalities in PEComas with therapeutic implications","volume":"39","author":"Agaram","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0117","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/PAS.0000000000000349","article-title":"TFE3 translocation-associated perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract: morphology, immunophenotype, differential diagnosis","volume":"39","author":"Schoolmeester","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0118","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/PAS.0000000000001239","article-title":"PGR Gene fusions identify a molecular subset of uterine epithelioid leiomyosarcoma with rhabdoid features","volume":"43","author":"Chiang","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0119","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/gcc.22518","article-title":"RNA-sequencing identifies novel GREB1-NCOA2 fusion gene in a uterine sarcoma with the chromosomal translocation t(2;8)(p25;q13)","volume":"57","author":"Brunetti","year":"2018","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1053\/j.semdp.2020.11.002_bib0120","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1097\/PAS.0000000000001265","article-title":"Clinicopathologic characterization of GREB1-rearranged uterine sarcomas with variable sex-cord differentiation","volume":"43","author":"Lee","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0121","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/PAS.0000000000001348","article-title":"Uterine Tumor Resembling Ovarian Sex Cord Tumor (UTROSCT): a morphologic and molecular study of 26 cases confirms recurrent NCOA1-3 rearrangement","volume":"44","author":"Goebel","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0122","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/PAS.0000000000001153","article-title":"Uterine tumor resembling ovarian sex cord tumor: a distinct entity characterized by recurrent NCOA2\/3 gene fusions","volume":"43","author":"Dickson","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0123","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/gcc.22694","article-title":"GREB1-CTNNB1 fusion transcript detected by RNA-sequencing in a uterine tumor resembling ovarian sex cord tumor (UTROSCT): a novel CTNNB1 rearrangement","volume":"58","author":"Croce","year":"2019","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1053\/j.semdp.2020.11.002_bib0124","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1097\/PAS.0000000000001543","article-title":"Uterine Tumor Resembling Ovarian Sex Cord Stromal Tumor (UTROSCT): a Series of 3 cases with extensive rhabdoid differentiation, malignant behavior, and ESR1-NCOA2 fusions","volume":"44","author":"Bennett","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0125","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.humpath.2018.01.007","article-title":"Uterine rhabdomyosarcoma in adults","volume":"74","author":"Pinto","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0126","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/ajcp\/70.2.217","article-title":"Rhabdomyosarcomas of the uterus","volume":"70","author":"Hart","year":"1978","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0127","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00004347-199710000-00013","article-title":"Pure pleomorphic rhabdomyosarcomas of the uterus","volume":"16","author":"Ordi","year":"1997","journal-title":"Int J Gynecol Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0128","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/01.pas.0000213352.87885.75","article-title":"Clinicopathologic features of rhabdomyosarcoma of gynecologic origin in adults","volume":"31","author":"Ferguson","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0129","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/PAS.0000000000000831","article-title":"Primitive neuroectodermal tumors of the female genital tract: a morphologic, immunohistochemical, and molecular study of 19 cases","volume":"41","author":"Chiang","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0130","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/modpathol.2016.140","article-title":"Evaluation of ETV4 and WT1 expression in CIC-rearranged sarcomas and histologic mimics","volume":"29","author":"Hung","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0131","article-title":"CIC-rearranged round cell (Ewing-like) sarcoma of the uterus: review of the literature","volume":"33","author":"Sedighim","year":"2020","journal-title":"Gynecol Oncol Rep"},{"key":"10.1053\/j.semdp.2020.11.002_bib0132","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/1097-0142(197910)44:4<1332::AID-CNCR2820440426>3.0.CO;2-#","article-title":"Ovarian mucinous tumors with sarcoma-like mural nodules: a report of seven cases","volume":"44","author":"Prat","year":"1979","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2020.11.002_bib0133","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/PAS.0b013e3181451b93","article-title":"Anaplastic carcinoma in mucinous ovarian tumors: a clinicopathologic study of 34 cases emphasizing the crucial impact of stage on prognosis, their histologic spectrum, and overlap with sarcomalike mural nodules","volume":"32","author":"Provenza","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0134","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/PAS.0000000000000875","article-title":"Molecular profiling reveals a clonal relationship between ovarian mucinous tumors and corresponding mural carcinomatous nodules","volume":"41","author":"Mesbah Ardakani","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0135","doi-asserted-by":"crossref","DOI":"10.1111\/his.14110","article-title":"SWI\/SNF protein and claudin-4 expression in anaplastic carcinomas arising in mucinous tumours of the ovary and retroperitoneum","author":"Chaudet","year":"2020","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2020.11.002_bib0136","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00000478-198508000-00001","article-title":"Ovarian Sertoli-Leydig cell tumors. A clinicopathological analysis of 207 cases","volume":"9","author":"Young","year":"1985","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0137","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/00000478-199609000-00004","article-title":"Malignant mesotheliomas presenting as ovarian masses. A report of nine cases, including two primary ovarian mesotheliomas","volume":"20","author":"Clement","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0138","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/01.pas.0000155161.55915.c3","article-title":"Gastrointestinal stromal tumors metastatic to the ovary: a report of five cases","volume":"29","author":"Irving","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0139","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.pap.0000213038.85704.e4","article-title":"From krukenberg to today: the ever present problems posed by metastatic tumors in the ovary: part I. Historical perspective, general principles, mucinous tumors including the krukenberg tumor","volume":"13","author":"Young","year":"2006","journal-title":"Adv Anat Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0140","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/PAP.0b013e3180504abf","article-title":"From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary","volume":"14","author":"Young","year":"2007","journal-title":"Part II. Adv Anat Pathol."},{"key":"10.1053\/j.semdp.2020.11.002_bib0141","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.ygyno.2005.01.016","article-title":"Lymphoepithelioma-like carcinoma of the uterine cervix: absence of Epstein-Barr virus, but presence of a multiple human papillomavirus infection","volume":"97","author":"Bais","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0142","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00404-007-0427-0","article-title":"Lymphoepithelioma-like carcinoma of the uterine cervix: absence of Epstein-Barr virus and high-risk human papilloma virus infection","volume":"277","author":"Kohrenhagen","year":"2008","journal-title":"Arch Gynecol Obstet"},{"key":"10.1053\/j.semdp.2020.11.002_bib0143","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/PGP.0000000000000446","article-title":"Inflammatory stroma of lymphoepithelioma-like carcinoma of the cervix: immunohistochemical study of 3 cases and review of the literature","volume":"37","author":"Philippe","year":"2018","journal-title":"Int J Gynecol Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0144","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/PGP.0000000000000483","article-title":"Human Papillomavirus (HPV)-associated lymphoepithelioma-like carcinoma of the vagina and anal canal: a rare variant of squamous cell carcinoma","volume":"38","author":"Scott","year":"2019","journal-title":"Int J Gynecol Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0145","article-title":"High-grade neuroendocrine carcinomas of the vulva: a clinicopathologic study of 16 cases","author":"Chen","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0146","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00000478-199702000-00002","article-title":"\"Proximal-type\" epithelioid sarcoma, a distinctive aggressive neoplasm showing rhabdoid features. Clinicopathologic, immunohistochemical, and ultrastructural study of a series","volume":"21","author":"Guillou","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0147","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1097\/PAS.0000000000000397","article-title":"SMARCB1-deficient vulvar neoplasms: a clinicopathologic, immunohistochemical, and molecular genetic study of 14 cases","volume":"39","author":"Folpe","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0148","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/jcp.2006.040931","article-title":"Ewing family of tumours involving the vulva and vagina: report of a series of four cases","volume":"60","author":"McCluggage","year":"2007","journal-title":"J Clin Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0149","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/IGC.0b013e3181acae33","article-title":"Primary vulvar Ewing sarcoma\/primitive neuroectodermal tumor: a report of 2 cases and review of the literature","volume":"19","author":"Cetiner","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1053\/j.semdp.2020.11.002_bib0150","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/his.13430","article-title":"Solitary fibrous tumour of the female genital tract: a clinicopathological analysis of 25 cases","volume":"72","author":"Yang","year":"2018","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2020.11.002_bib0151","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00004347-199910000-00012","article-title":"Dermatofibrosarcoma protuberans of the vulva: clinicopathologic and immunohistochemical analysis of four cases, one with fibrosarcomatous change, and review of the literature","volume":"18","author":"Ghorbani","year":"1999","journal-title":"Int J Gynecol Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0152","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/PAS.0b013e3181cf7fc1","article-title":"Dermatofibrosarcoma protuberans of the vulva: a clinicopathologic and immunohistochemical study of 13 cases","volume":"34","author":"Edelweiss","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0153","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1097\/PAS.0000000000001538","article-title":"Synovial sarcoma of the female genital tract: a protean mimic of mullerian neoplasia","volume":"44","author":"Kolin","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib0154","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/cup.13656","article-title":"Superficial sarcomas with CIC rearrangement are aggressive neoplasms: a series of eight cases","volume":"47","author":"Ko","year":"2020","journal-title":"J Cutan Pathol"},{"key":"10.1053\/j.semdp.2020.11.002_bib155","series-title":"Female Genital Tumours","year":"2020"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074025702030099X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074025702030099X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:22:44Z","timestamp":1760037764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S074025702030099X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":155,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S074025702030099X"],"URL":"https:\/\/doi.org\/10.1053\/j.semdp.2020.11.002","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Undifferentiated and dedifferentiated neoplasms of the female genital tract","name":"articletitle","label":"Article Title"},{"value":"Seminars in Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semdp.2020.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}